Drugs & medicalClass I

Fresenius Kabi USA, LLC recalls Ivenix Infusion System (IIS), Large Volume Pump, Model No. LVP-0004

Fluid ingress that can cause a loss of electrical funtion and failure of the Set ID Sensory, resulting in the prevention of infusion or halt of infusion.

Read the official notice →
Date
2023-04-19
Country
United States
Brand
Fresenius Kabi
Product
Ivenix Infusion System (IIS), Large Volume Pump, Model No. LVP-0004
Classification
Class I
Units
Domestic: CA, CO, NJ, WI, & UT. No foreign distribution.
Category
Drugs & medical
Source
FDA · Device

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More Fresenius Kabi recalls

  1. 2024-03-20
  2. US
    Drugs & medicalClass II

    Fresenius Kabi USA, LLC recalls LVP software of the Ivenix Infusion System (IIS), LVP-SW-0004

    Retroactively reported correction from 2022: A software defect may cause an incorrect (Fail-Stop) Alarm when an administration set is loaded with an upstream occlusion present, resulting in a non-recoverable…

    FDA · DeviceFresenius Kabi USA, LLCUS Nationwide distribution in the states of WI and NJ.Official notice →
  3. 2023-12-27
  4. US
    Drugs & medicalClass I

    Fresenius Kabi USA, LLC recalls Ivenix Infusion System (IIS), Large Volume Pump LVP-0004

    The device may experience mechanical interference on the Fluid Valve pins, which will trigger a Pump Problem alarm. The issue may lead to delay or interruption of therapy. Depending on the therapy and duration of…

    FDA · DeviceFresenius Kabi USA, LLCUS distribution to states of: CA, CO, NJ, UT, and WI.Official notice →
  5. 2023-10-04
  6. US
    Drugs & medicalClass II

    Fresenius Kabi USA, LLC recalls Ivenix Infusion System (IIS), Large Volume Pump (LVP) Software: 5.0.0 and 5.0.1 Part Number: LVP-SW-0004. Indicated for use in a hospital…

    Start-up time for the flow rate range greater than 50 ml/hr, and less than 200 ml/hr may exceed the specified 6 minutes, depending on the characteristics of air bubble entrapment within the Intermediate Pumping Chamber…

    FDA · DeviceFresenius Kabi USA, LLCUS Nationwide distribution in the states of NJ, WI.Official notice →
  7. 2023-01-25
  8. US
    Drugs & medicalClass II

    Fresenius Kabi USA, LLC recalls Sensorcaine (Bupivacaine HCl and Epinephrine Injection, USP) with Epinephrine 1:200,000 (as bitartrate), 0.5%, 250 mg per 50 mL (5 mg per…

    Subpotent Drug: Testing results below the defined limit for the epinephrine portion of this product.

    FDA · DrugFresenius Kabi USA, LLCNationwide in the USAOfficial notice →
  9. 2022-10-12
  10. US
    Drugs & medicalClass I

    Fresenius Kabi USA, LLC recalls Ivenix Infusion System (IIS), LVP Software; LVP-SW-0004 version 5.2.0

    The display screen may become frozen and unresponsive to user input, triggering an alarm that is evidenced by a buzzer sound and flashing red LEDs as a secondary notification. However, as the screen goes blank it does…

    FDA · DeviceFresenius Kabi USA, LLCDomestic distribution to NJ and WI.Official notice →
  11. 2022-03-30
  12. US
    Drugs & medicalClass I

    Fresenius Kabi USA, LLC recalls Sodium Acetate Injection, USP, 400 mEq / 100 mL (4 mEq / mL), packaged in 2 trays of 20 vials per shipper (NDC 63323-032-00), each vial:…

    Presence of particulate matter: particulates composed of carbon and oxygen with varying amounts of iron and trace amounts of sodium, silicon, chromium, aluminum and cellulose.

    FDA · DrugFresenius Kabi USA, LLCNationwide USAOfficial notice →
All 31 Fresenius Kabi recalls →

Other drugs & medical recalls in the United States

  1. 2023-04-19
  2. US
    Drugs & medicalClass II

    Merit Medical Systems, Inc. recalls Flex-Neck Catheter External Repair Kit REF CE-1400 LOT CE-1400/A

    Product that was built for design verification testing was inadvertently distributed to customers.

    FDA · DeviceMerit Medical Systems, Inc.U.S. Nationwide distribution in the states of MD, MI, OH, and TX. O.U.S.: N/AOfficial notice →
  3. US
    Drugs & medicalClass II

    Outset Medical, Inc. recalls Outset Tablo Model Numbers (REF): PN-0006000 PN-0007001 Tablo is a next generation, self-contained hemodialysis system (Hemodialysis…

    An observed trend of high conductivity dialysate alarms in a hemodialysis system as a result of introducing a software tool into the manufacturing process.

    FDA · DeviceOutset Medical, Inc.U.S. Nationwide distribution including in the states of AK, AL, AR, CA, CO,…Official notice →
  4. US
    Drugs & medicalClass II

    Church & Dwight Inc recalls Easy Read App associated with First Response Pregnancy Test Sticks - Intended use of converting analog pregnancy test results into text…

    Church & Dwight First Response Pregnancy Kits was marketed with the Easy Read App without a new 510k. There is also a potential for Easy Read App to be unable to reads the test results (i.e., no results reported on the…

    FDA · DeviceChurch & Dwight IncUS Nationwide distribution.Official notice →
  5. US
    Drugs & medicalClass III

    Focus Health Group Inc recalls Epinephrine Professional EMS, Epinephrine Convenience Kit, Epinephrine 1 mg/mL, Rx Only, Focus Health Group, Manufactured for: Focus…

    Labeling; Incorrect NDC number on outer carton of product.

    FDA · DrugFocus Health Group IncNationwide in the USAOfficial notice →
  6. US
    Drugs & medicalClass III

    Pfizer Inc. recalls MEKTOVI (binimetinib) tablets, 15 mg, 180-count bottle, Rx only, Distributed by: Array BioPharma Inc., a wholly owned subsidiary of Pfizer…

    Labeling: Incorrect or Missing Lot and/or Exp Date: The carton and bottle labels state an expiry date of March 2026; the correct expiration date is February 2025.

    FDA · DrugPfizer Inc.Nationwide in the USAOfficial notice →
  7. US
    Drugs & medicalClass III

    Pine Pharmaceuticals, LLC recalls Bevacizumab 2.5 mg/0.1 mL, Solution for Injection in 1mL, silicone free slip tip syringe, each Syringe supplied in individually labeled…

    Labeling: Incorrect or Missing Lot and/or Exp Date: Lot code on primary packaging is incorrect.

    FDA · DrugPine Pharmaceuticals, LLCNationwide in the USAOfficial notice →
See all drugs & medical recalls →